Incannex Healthcare Ltd Stock Current Asset
| IXHL Stock | USD 1.78 0.04 2.20% |
Incannex Healthcare Ltd fundamentals help investors to digest information that contributes to Incannex Healthcare's financial success or failures. It also enables traders to predict the movement of Incannex Stock. The fundamental analysis module provides a way to measure Incannex Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incannex Healthcare stock.
At this time, Incannex Healthcare's Total Current Assets are quite stable compared to the past year. Other Current Assets is expected to rise to about 10.9 M this year, although the value of Non Current Assets Total will most likely fall to about 802.8 K. Incannex | Current Asset |
Incannex Healthcare Ltd Company Current Asset Analysis
Incannex Healthcare's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Incannex Current Asset Historical Pattern
Today, most investors in Incannex Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incannex Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Incannex Healthcare current asset as a starting point in their analysis.
Incannex Healthcare Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Incannex Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Incannex Healthcare Ltd has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Incannex Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Incannex Healthcare from analyzing Incannex Healthcare's financial statements. These drivers represent accounts that assess Incannex Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Incannex Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.5B | 3.6B | 1.1B | 28.3M | 47.7M | 45.3M | |
| Enterprise Value | 2.5B | 3.6B | 1.1B | 6.7M | 42.2M | 40.1M |
Incannex Fundamentals
| Return On Equity | -1.15 | ||||
| Return On Asset | -0.57 | ||||
| Operating Margin | (538.33) % | ||||
| Current Valuation | 28.89 M | ||||
| Shares Outstanding | 17.64 M | ||||
| Shares Owned By Insiders | 25.86 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 27.53 K | ||||
| Price To Book | 4.87 X | ||||
| Price To Sales | 2,676 X | ||||
| Revenue | 12 K | ||||
| Gross Profit | 1.01 M | ||||
| EBITDA | (18.5 M) | ||||
| Net Income | (18.46 M) | ||||
| Cash And Equivalents | 37.5 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 373 K | ||||
| Current Ratio | 18.84 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (15.85 M) | ||||
| Short Ratio | 1.76 X | ||||
| Earnings Per Share | (1.36) X | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 32.11 M | ||||
| Total Asset | 17.05 M | ||||
| Retained Earnings | (110.67 M) | ||||
| Working Capital | 10.58 M | ||||
| Net Asset | 17.05 M |
About Incannex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incannex Healthcare Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incannex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incannex Healthcare Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incannex Healthcare Piotroski F Score and Incannex Healthcare Altman Z Score analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.